取出血栓中纤维蛋白与血小板富集特征标志活动性癌症相关卒中
活动性癌症组血栓的纤维蛋白/血小板比例显著高于其他两组,且该比例是区分癌症相关卒中的独立因素,≥65%可较准确预测癌症相关卒中。
要点
- 活动性癌症相关卒中血栓的纤维蛋白/血小板比例中位数为85.7%,显著高于心源性栓塞的43.9%和大动脉粥样硬化的42.5%。
- 纤维蛋白/血小板比例是区分癌症相关卒中与心源性栓塞及大动脉粥样硬化的唯一独立因素(OR 1.05,95%CI 1.02-1.08)。
- 纤维蛋白/血小板比例≥65%可较准确预测癌症相关卒中(AUC 0.84,P<0.001)。
核心结论
- 血管内治疗取出的血栓中高纤维蛋白/血小板成分可能是癌症相关卒中的提示指标。
研究设计与样本
- 所有入选血栓均行苏木精-伊红染色,定量血栓内纤维蛋白/血小板、红细胞和白细胞百分比。
主要发现
- 活动性癌症组血栓的纤维蛋白/血小板比例中位数为85.7%,心源性栓塞组为43.9%,大动脉粥样硬化组为42.5%,组间比较P<0.001。
- 纤维蛋白/血小板比例是区分癌症相关卒中与心源性栓塞及大动脉粥样硬化的唯一独立因素(OR 1.05,95%CI 1.02-1.08)。
- 纤维蛋白/血小板比例≥65%预测癌症相关卒中的曲线下面积为0.84(P<0.001)。
关键数值与推荐
- 纤维蛋白/血小板比例≥65%可较准确预测癌症相关卒中(AUC 0.84,P<0.001)。
- 纤维蛋白/血小板比例区分癌症相关卒中的独立因素OR为1.05(95%CI 1.02-1.08)。
临床怎么用
- 对于接受血管内治疗取栓的急性缺血性卒中患者,若血栓病理提示纤维蛋白/血小板比例高(如≥65%),应警惕活动性癌症相关卒中的可能,并进一步评估癌症。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: We aim to investigate whether histopathologic examination of thrombi retrieved from acute ischemic stroke patients undergoing endovascular treatment could distinguish cancer-related stroke from other etiologies. METHODS: Thrombi from patients undergoing endovascular treatment were analyzed. The etiology of stroke was divided into cardioembolism, large artery atherosclerosis, and active cancer groups. All selected thrombi were subjected to hematoxylin and eosin staining. The percentages of fibrin/platelets, red blood cells, and white blood cells within a thrombus were quantified. RESULTS: One-hundred fifty-two patients (active cancer, 19; cardioembolism, 107; large artery atherosclerosis, 26) were included. Thrombi from the active cancer group exhibited a higher fibrin/platelet composition than did those from the cardioembolism and large artery atherosclerosis groups (median, 85.7% versus 43.9% and 42.5%; P<0.001). Fibrin/platelet composition was the only independent factor (odds ratio, 1.05 [95% CI, 1.02-1.08]) in differentiating cancer-related stroke from stroke caused by cardioembolism and large artery atherosclerosis. A fibrin/platelet proportion of ≥65% accurately predicted cancer-related stroke (area under the curve, 0.84; P<0.001). CONCLUSIONS: In thrombi retrieved from patients undergoing endovascular treatment, a high fibrin/platelet composition was a probable indicator of cancer-related stroke.
引用
- Fu CH, Chen CH, Lin YH, et al. Fibrin and Platelet-Rich Composition in Retrieved Thrombi Hallmarks Stroke With Active Cancer. Stroke. 2020. PMID: 33138690. doi:10.1161/STROKEAHA.120.032069
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。